Drug-eluting stent versus bare-metal stent in acute ST-segment elevation myocardial infarction: a word of caution.
Gupta
Mohit
M
Los Angeles Biomedical Research Institute, 1124 West Carson Street, Torrance, CA 90502, USA.
Budoff
Matthew J
MJ
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D015331:Cohort Studies; D023903:Coronary Restenosis / Q000517:prevention & control / Q000628:therapy; D054855:Drug-Eluting Stents; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008670:Metals; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D017239:Paclitaxel / Q000008:administration & dosage*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011182:Postoperative Care; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D019233:Retreatment; D018570:Risk Assessment; D020123:Sirolimus / Q000008:administration & dosage*; D016019:Survival Analysis; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D008670:Metals; D010975:Platelet Aggregation Inhibitors; D017239:Paclitaxel; D020123:Sirolimus